These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Electrophilic affinity ligands for the phencyclidine (PCP) receptor. Lessor RA; Mattson MV; Rice KC; Jacobson AE NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571 [No Abstract] [Full Text] [Related]
5. Structure-function relationships in the inhibition of synaptosomal dopamine uptake by phencyclidine and analogues: potential correlation with binding site identified with [3H]phencyclidine. Vignon J; Lazdunski M Biochem Pharmacol; 1984 Feb; 33(4):700-2. PubMed ID: 6322809 [No Abstract] [Full Text] [Related]
6. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays. Contreras PC; Quirion R; O'Donohue TL NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347 [No Abstract] [Full Text] [Related]
7. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance. Junien JL; Leonard BE Clin Neuropharmacol; 1989 Oct; 12(5):353-74. PubMed ID: 2558790 [No Abstract] [Full Text] [Related]
8. [Recent topics of phencyclidine, the drug induces psychosis]. Nabeshima T Yakugaku Zasshi; 1987 Aug; 107(8):548-69. PubMed ID: 2828600 [No Abstract] [Full Text] [Related]
9. Phencyclidine-like effects of tetrahydroisoquinolines and related compounds. Gray NM; Cheng BK; Mick SJ; Lair CM; Contreras PC J Med Chem; 1989 Jun; 32(6):1242-8. PubMed ID: 2542555 [TBL] [Abstract][Full Text] [Related]
11. Phencyclidine: the new great mimic. Green JB; Stillner V Alaska Med; 1979 Jan; 21(1):6-9. PubMed ID: 426236 [No Abstract] [Full Text] [Related]
12. The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain. Loo PA; Braunwalder AF; Williams M; Sills MA Eur J Pharmacol; 1987 Mar; 135(2):261-3. PubMed ID: 3034630 [No Abstract] [Full Text] [Related]
14. Electroencephalographic (EEG), psychopharmacological, and receptor-binding profiles of 'phencyclinoids'. Mattia A; Leccese AP; Marquis KL; el-Fakahany EE; Moreton JE NIDA Res Monogr; 1986; 64():94-111. PubMed ID: 3012348 [No Abstract] [Full Text] [Related]
15. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Johnson KM; Jones SM Annu Rev Pharmacol Toxicol; 1990; 30():707-50. PubMed ID: 2160793 [No Abstract] [Full Text] [Related]
16. Alterations in rat brain [3H]-TCP binding following chronic phencyclidine administration. Massey BW; Wessinger WD Life Sci; 1990; 47(24):PL139-43. PubMed ID: 2176262 [TBL] [Abstract][Full Text] [Related]
17. Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation. Gundlach AL; Largent BL; Snyder SH Eur J Pharmacol; 1985 Jul; 113(3):465-6. PubMed ID: 2995073 [No Abstract] [Full Text] [Related]
18. A specific acylating agent for the [3H]phencyclidine receptors in rat brain. Rafferty MF; Mattson M; Jacobson AE; Rice KC FEBS Lett; 1985 Feb; 181(2):318-22. PubMed ID: 2982662 [TBL] [Abstract][Full Text] [Related]
19. The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Stirling JM; Cross AJ; Green AR Neuropharmacology; 1989 Jan; 28(1):1-7. PubMed ID: 2538766 [TBL] [Abstract][Full Text] [Related]
20. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat. Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]